Study | N | Incidence of GDM (%)1 | Ethnicity | Maternal age 2 | Gestational age at OGGT (weeks) 2 | Pre-gravid BMI2 | Study criteria for GDM treatment 3 mmol/L | |
---|---|---|---|---|---|---|---|---|
Aberg 2001 [12] Sweden | 4773 | 5.2 | Not reported | Not reported | 25-30 | Not reported | 2 hs PG > 9.0 | |
Black 2010 [13] USA | 8711 | 19.4 | White: 7.2; Black: 10.;1 Hispanic: 74.4; Asian: 7.4; Other: 0.9 | 29.1 ± 5.9 | 26.7 ± 2.9 | 27.5 ± 6.1 | At least 2 abnormal values: FPG ≥ 5.5; 1 hPG ≥ 10.8; 2 hPG ≥ 8.9 | |
EBDG 2001 [16] Brazil | 4998 | 7.5 | White: 44.9 Mixed: 41.1 Black: 13.6 Other: 0.4 | 27.8 ± 5.5 | 24-28 | 23.4 ± 4.0 | 2 hPG ≥ 10.0 | |
Forsbach 1997 [14] Mexico | 667 | 16.0 | Hispanic | 18 - 44 | 34.2 (24-40) | Not reported | 2 hPG > 10.0 | |
23316 | 11.4 | White: 48.3 Black: 11.6 Hispanic: 8.5 Asian: 29.0 Other: 2.6 | 29.2 ± 5.8 | 27.8 ± 1.8 | 27.7 ± 5.1 | FPG > 5.8; or 2 hPG > 10.0; or RPG ≥ 8.9 | ||
Khan 1994 [15] Pakistan | 1278 | 4.9 | Not reported | 26.7 ± 4.6 | 16 - 20 | Not reported | . At least 2 abnormal values: FPG > 5.8; 1 hPG > 10.3; 2 hPG > 7.8/3 hPG > 6.8 | |
Shirazian 2008 [17] Iran | 670 | 12.1 | Not reported | NR | 24-28 | Not reported | At least 2 abnormal values: FPG ≥ 5.5; 1 hPG ≥ 10.0; 2 hPG ≥ 8.3 | |
Sugaya 2000 [18] Japan | 416 | 32.5 | Asian | 30.3 ± 4.3 | 25.4 ± 8.2 | 22.4 ± 3.8 | At least 2 abnormal values: FPG ≥ 5.5; 1 hPG ≥ 10.0; 2 hPG ≥ 8.3 |